{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:42:22Z","timestamp":1792698142209,"version":"4.5.0"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA0806400"],"award-info":[{"award-number":["2022YFA0806400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.lfs.2023.121614","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T21:36:30Z","timestamp":1679607390000},"page":"121614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective"],"prefix":"10.1016","volume":"321","author":[{"given":"Lijun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.121614_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.lfs.2023.121614_bb0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.clinthera.2021.01.007","article-title":"Nonalcoholic fatty liver disease: a global perspective","volume":"43","author":"Wong","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2023.121614_bb0020","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.3390\/ijerph18105227","article-title":"Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors","volume":"18","author":"Juanola","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.lfs.2023.121614_bb0025","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121614_bb0030","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Yanlan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0035","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Rohit","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.121614_bb0040","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121614_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/20002297.2022.2110194","article-title":"Dysbiotic human oral microbiota alters systemic metabolism via modulation of gut microbiota in germ-free mice","volume":"14","author":"Yamazaki","year":"2022","journal-title":"J. Oral Microbiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0050","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/nu12051474","article-title":"The Firmicutes\/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.135320","article-title":"Diet as a modifiable factor in tumorigenesis: focus on microbiome-derived bile acid metabolites and short-chain fatty acids","volume":"410","author":"Ahmad","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.lfs.2023.121614_bb0060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.47750\/pnr.2022.13.S05.108","article-title":"The effect of smoking on liver enzymes and its functions","author":"Abdulkader","year":"2022","journal-title":"J. Pharm. Negat. Results"},{"key":"10.1016\/j.lfs.2023.121614_bb0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0070","series-title":"Mach. Life","first-page":"27","article-title":"The processes of living","author":"Goodsell","year":"1993"},{"key":"10.1016\/j.lfs.2023.121614_bb0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03263-19","article-title":"Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease","volume":"11","author":"Fei","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.lfs.2023.121614_bb0085","first-page":"3861","article-title":"Serum LPS and CD163 biomarkers confirming the role of gut dysbiosis in overweight patients with NASH, diabetes metab","volume":"13","author":"Hegazy","year":"2020","journal-title":"Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.lfs.2023.121614_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/nu12030699","article-title":"Adipokines and endotoxemia correlate with hepatic steatosis in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Nier","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111852","article-title":"Concanavalin A-rose Bengal bioconjugate for targeted gram-negative antimicrobial photodynamic therapy","volume":"206","author":"Cantelli","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.lfs.2023.121614_bb0100","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1111\/jcmm.15182","article-title":"Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path","volume":"24","author":"Glaser","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.1840080207","article-title":"Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis","volume":"8","author":"Lumsden","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41366-019-0430-0","article-title":"Circulating microbiota-derived metabolites: a \u201cliquid biopsy?","volume":"44","author":"Aragon\u00e8s","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.lfs.2023.121614_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104009","article-title":"Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis","volume":"142","author":"Wang","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.lfs.2023.121614_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/vetsci10010022","article-title":"Effects of continuous LPS induction on oxidative stress and liver injury in weaned piglets","volume":"10","author":"Zhou","year":"2022","journal-title":"Vet. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0135","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.3390\/nu14214467","article-title":"Preventive mechanism of lycopene on intestinal toxicity caused by cyclophosphamide chemotherapy in mice by regulating TLR4-MyD88\/TRIF-TRAF6 signaling pathway and gut-liver axis","volume":"14","author":"Pan","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2023.121614_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jcb.27547","article-title":"Recent advances in endotoxin tolerance","volume":"120","author":"Liu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2023.121614_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4254\/wjh.v7.i3.425","article-title":"Gut-liver axis in liver cirrhosis: how to manage leaky gut and endotoxemia","volume":"7","author":"Fukui","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/07315724.2002.10719234","article-title":"Endotoxin-mediated hepatic lipid accumulation during parenteral nutrition in rats","volume":"21","author":"Dickerson","year":"2002","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0160","first-page":"2742","article-title":"The impact of small doses of LPS on NASH in high sucrose and high fat diet induced rats","volume":"18","author":"Guo","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0165","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/jgh.13488","article-title":"Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice: endotoxin and liver damage","volume":"32","author":"Jin","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3892\/mmr.2014.2995","article-title":"Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model","volume":"11","author":"Douhara","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0175","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/jgh.12510","article-title":"Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis: endotoxin and nonalcoholic steatohepatitis","volume":"29","author":"Yuan","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/apt.14119","article-title":"Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease","volume":"46","author":"Pang","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2023.121614_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/diagnostics9040205","article-title":"Diet-induced rat model of gradual development of non-alcoholic fatty liver disease (NAFLD) with lipopolysaccharides (LPS) secretion","volume":"9","author":"Maciejewska","year":"2019","journal-title":"Diagnostics"},{"key":"10.1016\/j.lfs.2023.121614_bb0190","article-title":"Effects of peptidoglycan on the development of steatohepatitis","volume":"1865","author":"Jin","year":"2020","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2023.121614_bb0195","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.it.2017.07.004","article-title":"NOD1 and NOD2: beyond peptidoglycan sensing","volume":"38","author":"Keestra-Gounder","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2023.121614_bb0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00417-012-2130-5","article-title":"Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NF\u03baB and NOD2-EGFR","volume":"251","author":"Ju\u00e1rez-Verdayes","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.lfs.2023.121614_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13258-015-0369-z","article-title":"Characterization of a nucleotide-oligomerization domain (NOD) like receptor C5 (NLRC5) subfamily member from black rockfish (Sebastes schlegelii), portraying its transcriptional responses against immune stimulants","volume":"38","author":"Elvitigala","year":"2016","journal-title":"Genes Genomics"},{"key":"10.1016\/j.lfs.2023.121614_bb0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12902","article-title":"NOD1 and NOD2 in inflammatory and infectious diseases","volume":"297","author":"Trindade","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2023.121614_bb0215","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1038\/s41598-020-65051-8","article-title":"Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"10","author":"Pan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0220","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1096\/fj.09-141929","article-title":"Tlr2 is critical for diet-induced metabolic syndrome in a murine model","volume":"24","author":"Himes","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2023.121614_bb0225","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00125-010-1747-3","article-title":"Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet","volume":"53","author":"Ehses","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2023.121614_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106368","article-title":"Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-\u03baB pathways","volume":"82","author":"Wu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2023.121614_bb0235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-230X-10-52","article-title":"Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis","volume":"10","author":"Rivera","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116793","article-title":"Microbiota determines insulin sensitivity in TLR2-KO mice","volume":"234","author":"Guadagnini","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0245","series-title":"The impact and mechanism of peptidoglycan on nonalcoholic fatty liver disease","author":"Lai","year":"2018"},{"key":"10.1016\/j.lfs.2023.121614_bb0250","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.celrep.2017.02.027","article-title":"Circulating NOD1 activators and hematopoietic NOD1 contribute to metabolic inflammation and insulin resistance","volume":"18","author":"Chan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0255","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/db11-0004","article-title":"NOD1 activators link innate immunity to insulin resistance","volume":"60","author":"Schertzer","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2023.121614_bb0260","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1152\/ajpendo.00181.2020","article-title":"NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice","volume":"319","author":"Cavallari","year":"2020","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.121614_bb0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.15252\/emmm.201404169","article-title":"Defective NOD 2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance","volume":"7","author":"Denou","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0270","series-title":"Unmethylated Cytosine Phosphate Guanine DNA (CpG-DNA) Exacerbates Liver Kupffer Cells (KCs) Inflammation Through Toll-like Receptor 9 (TLR9) in Diabetic Rats, In Review","author":"Cai","year":"2021"},{"key":"10.1016\/j.lfs.2023.121614_bb0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3350\/cmh.2020.0046","article-title":"Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?","volume":"26","author":"Jeong","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0280","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2023.121614_bb0285","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/liv.14571","article-title":"Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients","volume":"40","author":"G\u00f3mez-Hurtado","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2023.121614_bb0290","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13827","article-title":"Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis","volume":"235","author":"Luo","year":"2022","journal-title":"Acta Physiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0295","series-title":"Proc. Book Int. Conf. Exhib. Indones. Med. Educ. Res. Inst","first-page":"75","article-title":"Innate immune response in non alcoholic fatty liver disease: an overview of alterations in TLR9, macrophages, and TNF\u03b1","author":"Supriatna","year":"2022"},{"key":"10.1016\/j.lfs.2023.121614_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107265","article-title":"IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis","volume":"9","author":"Negrin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2023.121614_bb0305","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1\u03b2-dependent suppression of peroxisome proliferator-activated receptor \u03b1 activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121614_bb0315","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1042\/CS20160838","article-title":"TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival","volume":"131","author":"Mridha","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0320","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1515\/cclm-2021-1176","article-title":"Determination of individual bile acids in acute respiratory distress syndrome reveals a specific pattern of primary and secondary bile acids and a shift to the acidic pathway as an adaptive response to the critical condition","volume":"60","author":"Harnisch","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0325","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0335","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","article-title":"Bile acid signaling in inflammatory bowel diseases","volume":"66","author":"Fiorucci","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0340","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep4.1485","article-title":"Bile acid diarrhea and NAFLD: shared pathways for distinct phenotypes","volume":"4","author":"Weaver","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.lfs.2023.121614_bb0345","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.7150\/ijbs.44774","article-title":"Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of lipid metabolism","volume":"16","author":"Kumari","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2023.121614_bb0355","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121614_bb0360","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1096\/fj.201902687R","article-title":"Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis","volume":"34","author":"Gupta","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2023.121614_bb0365","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121614_bb0370","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/microorganisms8060925","article-title":"Bile acid sequestrant, sevelamer ameliorates hepatic fibrosis with reduced overload of endogenous lipopolysaccharide in experimental nonalcoholic steatohepatitis","volume":"8","author":"Tsuji","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.lfs.2023.121614_bb0375","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1074\/jbc.RA119.011913","article-title":"Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet\u2013fed mice","volume":"295","author":"Takahashi","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121614_bb0380","doi-asserted-by":"crossref","first-page":"23058","DOI":"10.1074\/jbc.M116.731042","article-title":"Sevelamer improves steatohepatitis, inhibits liver and intestinal farnesoid X receptor (FXR), and reverses innate immune dysregulation in a mouse model of non-alcoholic fatty liver disease","volume":"291","author":"McGettigan","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121614_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1665-2681(19)30911-1","article-title":"Effects of bile acid sequestration on hepatic steatosis in obese mice","volume":"13","author":"Sol\u00eds","year":"2014","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0390","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037961","article-title":"Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease","volume":"10","author":"Kessoku","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.lfs.2023.121614_bb0395","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12072-022-10296-w","article-title":"Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice","volume":"16","author":"Hartmann","year":"2022","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.lfs.2023.121614_bb0400","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"For the San Diego integrated NAFLD research consortium (SINC), effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet\u2013fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in ldlr-\/-.Leiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lfs.2023.121614_bb0415","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.024","article-title":"Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study","volume":"73","author":"Newsome","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0420","first-page":"1464","article-title":"Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study","volume":"23","author":"Laurin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0425","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.20092","article-title":"Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial","volume":"39","author":"Lindor","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0430","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.23727","article-title":"The NASH study group, high-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Leuschner","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0435","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2023.121614_bb0440","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121614_bb0445","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2023.121614_bb0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2014.05.072","article-title":"Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction","volume":"450","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.121614_bb0455","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0460","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.3748\/wjg.v20.i39.14430","article-title":"FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation","volume":"20","author":"Yao","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0465","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.112.196519","article-title":"Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl Ester transfer protein transgenic low-density lipoprotein receptor (\u2212\/\u2212) mice","volume":"343","author":"Hambruch","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2023.121614_bb0470","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.10.018","article-title":"EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0475","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/biomedicines9010060","article-title":"The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model","volume":"9","author":"Schwabl","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2023.121614_bb0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial","volume":"72","author":"Patel","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0485","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hep4.1368","article-title":"Tropifexor-mediated abrogation of steatohepatitis and fibrosis is associated with the antioxidative gene expression profile in rodents","volume":"3","author":"Hernandez","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.lfs.2023.121614_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2019.12.129","article-title":"Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR part C interim results","volume":"52","author":"Lucas","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2023.121614_bb0495","doi-asserted-by":"crossref","first-page":"S682","DOI":"10.1016\/S0168-8278(20)31826-2","article-title":"MET409, a potent, non-bile acid sustained FXR agonist, improves NAFLD activity score and exerts anti-fibrotic effects in a diet-induced obese mouse model of biopsy-confirmed fibrosing NASH","volume":"73","author":"Veidal","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0500","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0505","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice: zhou et al","volume":"1","author":"Zhou","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.lfs.2023.121614_bb0510","doi-asserted-by":"crossref","first-page":"S694","DOI":"10.1016\/S0168-8278(15)31133-8","article-title":"P0932: treatment with NGM282 significantly improves liver histopathology in a mouse model of non-alcoholic steatohepatitis (NASH)","volume":"62","author":"Luo","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0515","doi-asserted-by":"crossref","DOI":"10.2337\/db18-1-LB","article-title":"NGM282 significantly reduces hepatic steatosis independent of type 2 Diabetes (T2D) status or statin usage\u2014results from a phase 2 trial in patients with nonalcoholic steatohepatitis (NASH)","volume":"67","author":"Depaoli","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2023.121614_bb0520","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/14728222.2021.1999416","article-title":"A short report on NGM282\/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"25","author":"Roberts","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2023.121614_bb0525","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01369-21","article-title":"The short-chain fatty acids propionate and butyrate augment adherent-invasive Escherichia coli virulence but repress inflammation in a human intestinal enteroid model of infection","volume":"9","author":"Pace","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.lfs.2023.121614_bb0530","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121614_bb0535","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116125118","article-title":"Local acetate inhibits brown adipose tissue function","volume":"118","author":"Sun","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0540","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1152\/ajpendo.00229.2010","article-title":"Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet","volume":"300","author":"Bjursell","year":"2011","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.121614_bb0545","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1073\/pnas.0808567105","article-title":"Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41","volume":"105","author":"Samuel","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0550","doi-asserted-by":"crossref","first-page":"G900","DOI":"10.1152\/ajpgi.00265.2013","article-title":"Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids","volume":"305","author":"den Besten","year":"2013","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0555","first-page":"e1","article-title":"Short-chain fatty acids and SCFA-producing bacteria in NAFLD patients are associated with an increased Th17\/rTreg ratio and hepatic disease progression","volume":"55","author":"Rau","year":"2017","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0560","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu11010051","article-title":"Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors","volume":"11","author":"de la Cuesta-Zuluaga","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200597","article-title":"Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41\/43-CaMKII\/HDAC1-CREB pathway","volume":"67","author":"Zheng","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2023.121614_bb0570","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1152\/ajpendo.00053.2012","article-title":"Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice","volume":"303","author":"Vinolo","year":"2012","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2023.121614_bb0575","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2023.121614_bb0580","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12876-020-01194-2","article-title":"Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Takai","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0585","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1017\/S0007114515003621","article-title":"Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)","volume":"114","author":"Jin","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0590","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1038\/s41598-017-06447-x","article-title":"Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice","volume":"7","author":"Weitkunat","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0595","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fphar.2018.00533","article-title":"The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor \u03b1-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121614_bb0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsec\/fiu002","article-title":"Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease","volume":"91","author":"Michail","year":"2015","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.lfs.2023.121614_bb0605","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.3390\/nu14245355","article-title":"Precision nutrition in NAFLD: effects of a high-fiber intervention on the serum metabolome of NAFD patients\u2014a pilot study","volume":"14","author":"Stachowska","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0610","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1038\/s41598-019-48775-0","article-title":"Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans","volume":"9","author":"M\u00fcller","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0615","first-page":"1","article-title":"Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut\u2013liver axis","author":"Han","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0620","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/metabo12010064","article-title":"Unlike glycerophosphocholine or choline chloride, dietary phosphatidylcholine does not increase plasma trimethylamine-N-oxide levels in Sprague-Dawley Rats","volume":"12","author":"Shirouchi","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2023.121614_bb0625","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/19390211.2019.1639875","article-title":"Choline: the neurocognitive essential nutrient of interest to obstetricians and gynecologists","volume":"17","author":"Wallace","year":"2020","journal-title":"J. Diet. Suppl."},{"key":"10.1016\/j.lfs.2023.121614_bb0630","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nutres.2022.02.004","article-title":"Lower plasma glutathione, choline, and betaine concentrations are associated with fatty liver in postmenopausal women","volume":"101","author":"Muzsik-Kazimierska","year":"2022","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2023.121614_bb0635","doi-asserted-by":"crossref","first-page":"G634","DOI":"10.1152\/ajpgi.00249.2009","article-title":"Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease","volume":"298","author":"Wang","year":"2010","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0640","first-page":"1399","article-title":"Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation","volume":"22","author":"Buchman","year":"1995","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.lfs.2023.121614_bb0645","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032011000100015","article-title":"Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis","volume":"48","author":"Marcolin","year":"2011","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0650","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1017\/S1431927620024265","article-title":"Effect of betaine supplementation on liver tissue and ultrastructural changes in methionine\u2013choline-deficient diet-induced NAFLD","volume":"26","author":"Veskovi\u0107","year":"2020","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.lfs.2023.121614_bb0655","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jn\/nxab367","article-title":"Assessment of dietary choline intake, contributing food items, and associations with one-carbon and lipid metabolites in middle-aged and elderly adults: the Hordaland health study","volume":"152","author":"Van Parys","year":"2022","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0660","doi-asserted-by":"crossref","first-page":"H1474","DOI":"10.1152\/ajpheart.00584.2019","article-title":"Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism","volume":"318","author":"Pathak","year":"2020","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0665","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnut.2018.00061","article-title":"Betaine and choline improve lipid homeostasis in obesity by participation in mitochondrial oxidative demethylation","volume":"5","author":"Sivanesan","year":"2018","journal-title":"Front. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0670","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2020.03.180","article-title":"Effect of methionine\/choline-deficient diet and high-fat diet-induced steatohepatitis on mitochondrial homeostasis in mice","volume":"527","author":"Arao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.121614_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.453","article-title":"Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells","volume":"4","author":"Sanchez-Lopez","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.121614_bb0680","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nlm.2018.08.009","article-title":"Choline ameliorates adult learning deficits and reverses epigenetic modification of chromatin remodeling factors related to adolescent nicotine exposure","volume":"155","author":"Gitik","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.lfs.2023.121614_bb0685","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2015.11.043","article-title":"Betaine prevented fructose-induced NAFLD by regulating LXR\u03b1\/PPAR\u03b1 pathway and alleviating ER stress in rats","volume":"770","author":"Ge","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121614_bb0690","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00394-020-02362-6","article-title":"Betaine prevented high-fat diet-induced NAFLD by regulating the FGF10\/AMPK signaling pathway in ApoE\u2212\/\u2212 mice","volume":"60","author":"Chen","year":"2021","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0695","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1007\/s10620-013-2775-x","article-title":"Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and toll-like receptor 4 expression in rats","volume":"58","author":"Zhang","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0700","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jnutbio.2013.11.007","article-title":"Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet","volume":"25","author":"Wang","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2023.121614_bb0705","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/liv.13249","article-title":"Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency","volume":"37","author":"Sookoian","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2023.121614_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.07.010","article-title":"Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes","volume":"47","author":"Le\u00f3n-Mimila","year":"2021","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.lfs.2023.121614_bb0715","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1872-034X.2012.00976.x","article-title":"Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study: plasma free choline levels in NAFLD","volume":"42","author":"Imajo","year":"2012","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2023.121614_bb0720","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0725","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13668-018-0252-z","article-title":"Trimethylamine N-oxide and risk of cardiovascular disease and mortality","volume":"7","author":"Kanitsoraphan","year":"2018","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0730","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/metabo12121243","article-title":"Trimethylamine N-oxide levels in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Theofilis","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2023.121614_bb0735","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900257","article-title":"Trimethylamine N -oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid X receptor signaling in nonalcoholic fatty liver disease","volume":"63","author":"Tan","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2023.121614_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.060","article-title":"Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine","volume":"594","author":"Shi","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.121614_bb0745","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/liv.14963","article-title":"Circulating trimethylamine- N -oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease","volume":"41","author":"Flores-Guerrero","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2023.121614_bb0750","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3390\/nu10121971","article-title":"Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome","volume":"10","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0755","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jbiosc.2014.03.001","article-title":"Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet","volume":"118","author":"Gao","year":"2014","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.lfs.2023.121614_bb0760","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3748\/wjg.v25.i20.2450","article-title":"Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats","volume":"25","author":"Zhao","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2023.121614_bb0765","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0770","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2023.121614_bb0775","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"57","author":"Volynets","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2023.121614_bb0780","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2174\/1381612826666200122152417","article-title":"Nonalcoholic fatty liver disease versus alcohol-related liver disease: is it really so Different?","volume":"26","author":"Craciun","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2023.121614_bb0785","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jgh.15027","article-title":"Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"35","author":"Chen","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0790","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.freeradbiomed.2013.09.009","article-title":"CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis","volume":"65","author":"Abdelmegeed","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0795","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/acer.12813","article-title":"The role of miR-212 and iNOS in alcohol-induced intestinal barrier dysfunction and steatohepatitis","volume":"39","author":"Tang","year":"2015","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.lfs.2023.121614_bb0800","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/gutjnl-2014-308379","article-title":"Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease","volume":"65","author":"Engstler","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121614_bb0805","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","article-title":"Microbiome-derived ethanol in nonalcoholic fatty liver disease","volume":"28","author":"Meijnikman","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0810","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archinte.163.11.1329","article-title":"Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women","volume":"163","author":"Wannamethee","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0815","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites: critical regulators in NAFLD","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2023.121614_bb0820","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1096\/fj.201800544","article-title":"The gut microbiota metabolite indole alleviates liver inflammation in mice","volume":"32","author":"Beaumont","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2023.121614_bb0825","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jn\/nxab032","article-title":"Hepatoprotective effects of indole, a gut microbial metabolite, in leptin-deficient obese mice","volume":"151","author":"Knudsen","year":"2021","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2023.121614_bb0830","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.31115","article-title":"Indole alleviates diet-induced hepatic steatosis and inflammation in a manner involving myeloid cell 6-Phosphofructo-2-Kinase\/Fructose-2,6-biphosphatase 3","volume":"72","author":"Ma","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2023.121614_bb0835","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2023.121614_bb0840","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110442","article-title":"Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation","volume":"99","author":"Zhang","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2023.121614_bb0850","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1007\/s11695-021-05321-0","article-title":"Role of Indole-3-acetic acid in NAFLD amelioration after sleeve gastrectomy","volume":"31","author":"Wang","year":"2021","journal-title":"Obes. Surg."},{"key":"10.1016\/j.lfs.2023.121614_bb0855","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/nu13103509","article-title":"Indole-3-propionic acid, a gut-derived tryptophan metabolite, associates with hepatic fibrosis","volume":"13","author":"Sehgal","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2023.121614_bb0860","first-page":"1","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2023.121614_bb0865","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/acs.jafc.0c05205","article-title":"Indole-3-propionic acid improved the intestinal barrier by enhancing epithelial barrier and mucus barrier","volume":"69","author":"Li","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2023.121614_bb0870","first-page":"917","article-title":"Indole-3-propionic acid-aggravated CCl4-induced liver fibrosis via the TGF-\u03b21\/Smads signaling pathway","volume":"9","author":"Liu","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153427","article-title":"Bilirubin binding to PPAR\u03b1 inhibits lipid accumulation","volume":"11","author":"Stec","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2023.121614_bb0880","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3350\/cmh.2012.18.4.357","article-title":"Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Byoung Kuk","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.lfs.2023.121614_bb0885","article-title":"Therapeutic efficacy and safety of yinzhihuang granules with phototherapy in neonatal pathologic jaundice: an updated systematic review and meta-analysis","volume":"100","author":"Feng","year":"2022","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.lfs.2023.121614_bb0890","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tem.2018.01.002","article-title":"Bilirubin in the liver-gut signaling axis","volume":"29","author":"Hamoud","year":"2018","journal-title":"Trends Endocrinol. Metab. TEM."},{"key":"10.1016\/j.lfs.2023.121614_bb0895","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.redox.2015.06.008","article-title":"Bilirubin inhibits the up-regulation of inducible nitric oxide synthase by scavenging reactive oxygen species generated by the toll-like receptor 4-dependent activation of NADPH oxidase","volume":"5","author":"Idelman","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.121614_bb0900","article-title":"Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease: a mendelian randomization study","volume":"9","author":"Lei","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2023.121614_bb0905","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/antiox12010170","article-title":"Bilirubin levels are negatively correlated with adiposity in obese men and women, and its catabolized product, urobilin, is positively associated with insulin resistance","volume":"12","author":"Kipp","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.lfs.2023.121614_bb0910","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2009.04.003","article-title":"Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial","volume":"58","author":"Charlotte","year":"2009","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.lfs.2023.121614_bb0915","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594574","article-title":"Bilirubin nanoparticles reduce diet-induced hepatic steatosis, improve fat utilization, and increase plasma \u03b2-hydroxybutyrate","volume":"11","author":"Hinds","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121614_bb0920","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/ismej.2014.79","article-title":"Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL\/6 strains under high-fat diet","volume":"8","author":"Walker","year":"2014","journal-title":"ISME J."},{"key":"10.1016\/j.lfs.2023.121614_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111839","article-title":"Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity","volume":"562","author":"Miranda","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2023.121614_bb0930","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JOE-20-0139","article-title":"Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin","volume":"247","author":"Silva-Veiga","year":"2020","journal-title":"J. Endocrinol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523002485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523002485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T04:45:14Z","timestamp":1736311514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523002485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":186,"alternative-id":["S0024320523002485"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121614","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121614"}}